Возраст домена | 20 лет |
Дата окончания | Через 3 года |
PR | 6 |
ИКС | 0 |
Страниц в Google | 782 |
Страниц в Яндексе | 237 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 750482 |
Alexa Country | 500256 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Astellas Pharma US | Changing Tomorrow | Home
n/a
Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company
UTF-8
56.38 КБ
680
5 417 симв.
4 619 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
astellas.com | 60 | 6 |
0 | 207418 | 17538 | |
astellas.eu | 24 | 5 |
0 | 5267637 | Нет данных | |
astellasaccess.com | 23 | 4 |
0 | Нет данных | Нет данных | |
scienceparkillinois.com | 20 | 4 |
0 | 7411863 | Нет данных | |
astellasventure.com | 12 | 5 |
0 | 7021128 | Нет данных | |
lexiscan.com | 11 | n/a | 0 | 5266276 | Нет данных | |
astellasusafoundation.org | 11 | 5 |
0 | 12539743 | Нет данных | |
prograf.com | 9 | 3 |
0 | 7291541 | Нет данных | |
astellas-europe.co.uk | 9 | 5 |
10 | Нет данных | Нет данных | |
ambisome.com | 7 | 4 |
0 | 8072588 | Нет данных | |
phrma.org | 2 | 7 |
0 | 364326 | 97389 | |
medoc-web.com | 1 | 4 |
0 | 10184738 | Нет данных | |
ifpma.org | 1 | 6 |
0 | 1231902 | 362446 | |
forbes.com | 1 | 8 |
0 | 289 | 109 | |
citeline.com | 1 | 5 |
10 | 1219507 | 208608 | |
centerwatch.com | 1 | 7 |
20 | 117553 | 35782 | |
biospace.com | 1 | 7 |
0 | 70695 | 19400 | |
biopharmaservices.ca | 1 | 4 |
0 | 1287373 | 64432 | |
bayerpharma.com | 1 | 6 |
40 | 56932 | 33278 | |
algopharm.com | 1 | 4 |
10 | 573849 | 23357 | |
Еще 30 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 11 Ноября 2016 ) | |
Количество ссылок на сайт | 2933 |
Количество доменов, которые ссылаются на сайт | 297 |
Количество найденных анкоров | 93 |
Исходящие (внешние) ссылки домена | 384 |
Количество доменов, на которые ссылается сайт | 48 |
Количество исходящих анкоров | 44 |
Внешние ссылки главной страницы ( 13 ) | |
astellas.com/us/system/files/astellas_fact_sheet_9.5.19.pdf | Astellas Fact Sheet |
astellas.com/us/system/files/astellas_us_brochure_0.pdf | Corporate Brochure |
astellas.com/us/system/files/AstellasAmericas2017CSRReportCa... | CSR Report Card |
astellas.com/us/system/files/adr_list_062119_clean_0.pdf | Authorized Distributors of Records |
astellas.com/us/system/files/CSRReportCard.pdf | CSR Report CardThe 2017 CSR Report Card reviews our progress and celebrates our achievements over the past year.Read More |
astellascareers.jobs/ | Careers |
astellas.com/us/news/4651 | Astellas Oncology Announces Grand Prize Winner of 2019 C3 Prize® to Improve Cancer Care ... |
astellas.com/us/news/4581 | Astellas Commits Nearly $13 Million to Fund Boston-Area Start-Up Innovation in Cell and Gene Therapy ... |
astellas.com/us/news/4721 | FDA Grants Accelerated Approval to Astellas' and Seattle Genetics' PADCEV™ (enfortumab vedotin-ejfv) for People with Locally Adv... |
astellas.com/en/investors | InvestorsAccess financial information, investor relations library, analyst coverage and moreRead More |
facebook.com/AstellasUS/ | <img> |
linkedin.com/company/astellas-pharma/ | <img> |
twitter.com/AstellasUS | <img> |
Внутренние ссылки главной страницы ( 90 ) | |
#blocktabs-homepage_news--50 | Latest |
/us | US |
/us/about | About |
/us/about/product | U.S. Products |
/us/about/medical-safety | Medical Safety |
/us/about/sds | Safety Data Sheets (v 3.0) |
/us/about/philosophy | Philosophy |
/us/about/charter-of-corporate-conduct | Charter of Corporate Conduct |
/us/about/corporate-information | U.S. Corporate ProfileLearn more about Astellas U.S.Read More |
/us/about/locations | Locations |
/us/about/group-code-of-conduct | Group Code of Conduct |
/us/about/us-leadership | Leadership |
/us/about/percival-barretto-ko | Percival Barretto-Ko |
/us/about/joe-devaney | Joe Devaney |
/us/about/shontelle-dodson | Shontelle Dodson |
/us/about/walt-johnston | Walt Johnston |
/us/about/moyra-knight | Moyra Knight |
/us/about/chieko-mori | Chieko Mori |
/us/about/Mark-Niemaszek | Mark Niemaszek |
/us/about/mark-reisenauer | Mark Reisenauer |
/us/about/regulations | Regulations |
/us/about/state-regulations | State Regulations |
/us/about/california-declaration-of-comprehensive-compliance... | California Declaration of Comprehensive Compliance Program |
/us/about/vermonts-pharmaceutical-marketer-price-disclosure | Vermont’s Pharmaceutical Marketer Price Disclosure |
/us/about/wholesale-acquisition-cost-information-for-colorad... | Wholesale Acquisition Cost Information for Colorado Prescribers |
/us/about/consumer-product-safety-commission-regulations | Consumer Product Safety Commission Regulations |
/us/about/company-facts-and-infographics | Company Facts |
/us/about/policies-and-position-statements | Policies & Position Statements |
/us/contact-us | CONTACT US |
/us/about/supplier-hub | Procurement |
/us/about/procurement-news | Procurement News |
/us/about/prospective-suppliers | Prospective Suppliers |
/us/about/existing-suppliers | Existing Suppliers |
/us/about/contacts | Contact & Resources |
/us/about/po-terms-and-conditions | PO terms and conditions |
/us/about/vision-and-strategy | Vision & Strategy |
/us/about/governance-0 | Governance |
/us/about/history | History |
/us/innovation | Innovation |
/us/innovation/partnering | Partnering |
/us/innovation/track-record | Track Record |
/us/innovation/areas-of-interest | Areas of Interest |
/us/innovation/register-form | Partnering Inquiry |
/us/innovation/r-and-d | R&D |
/us/innovation/approach | Approach |
/us/innovation/clinical-trials | Clinical TrialsThis website provides access to information from Astellas sponsored clinical trials and the purpose is not to pro... |
/us/innovation/ethics-and-principles | Ethics & Principles |
/us/innovation/pipeline | Pipeline |
/us/responsibility | Corporate Responsibility |
/us/responsibility/our-commitment | Our Commitment |
/us/responsibility/commitment-to-transparency | Commitment To Transparency |
/us/responsibility/us-sunshine-act-overview | U.S. Sunshine Act Overview |
/us/responsibility/changing-tomorrow-day | Changing Tomorrow Day |
/us/responsibility/corporate-grants-contributions | Corporate Grants |
/us/responsibility/access-accelerated | Access Accelerated |
/us/responsibility/employee-impact | Employee Impact |
/us/responsibility/patient-advocacy | Patient Advocacy |
/us/responsibility/awards-recognition | Awards & Recognition |
/us/news | View All >> |
/us/news/news-releases | News Releases |
/us/news/stories | Stories |
/us/news/corporate?tab=latest&page=0 | Corporate |
/us/news/corporate-awards | Corporate Awards |
/us/news/corporate-social-responsibility | Corporate Social Responsibility |
/us/news/our-people | Our People |
/us/news/therapeutic-area-news | Therapeutic Area News |
newsroom.astellas.us/the-astellas-way | The Astellas Way Blog |
newsroom.astellas.us/feature-stories | Feature StoriesFeature Stories showcase the people and programs that bring to life the Astellas Way values and culture.Read More |
newsroom.astellas.us/video-gallery | Video Gallery |
newsroom.astellas.us/index.php?s=31383 | Annual Report 2018 |
newsroom.astellas.us/media-inquiries | Media Inquiries |
/us/patients-and-caregivers | Patients & CaregiversLearn more about resources designed to meet the needs of patients and caregiversRead More |
/us/patients-and-caregivers/support-for-patients | Support for Patients |
/us/patients-and-caregivers/astellas-pharma-support-solution... | Astellas Pharma Support Solutions |
/us/patients-and-caregivers/myifi | MyIFI |
/us/patients-and-caregivers/resources-and-contacts | Resources and Contacts |
/us/patients-and-caregivers/issues-that-matter-to-you | Issues that Matter to You |
/us/worldwide | WORLDWIDE - US |
newsroom.astellas.us/the-astellas-way?item=1126 | Powering on with the Mitochondria: Kidney Disease & Beyond By Effie Tozzo, PhD, Senior ... |
newsroom.astellas.us/2019-12-05-Astellas-and-MBC-BioLabs-Ann... | Astellas and MBC BioLabs Announce Golden Ticket Winners - Supporting Biotech Start-Ups to Accelerate Innovative Science ... |
/us/news/14976 | Read More |
/us/news/14896 | Read More |
/us/news/14866 | Read More |
/us/news/4721 | Read More |
/us/news/4711 | Read More |
/us/news/4706 | Read More |
/us/sitemap | SITE MAP |
/us/privacy-policy | PRIVACY POLICY |
/us/accessibility | ACCESSIBILITY |
/us/legal | LEGAL DISCLAIMER |
Domain Name: astellas.us
Registry Domain ID: D6104699-US
Registrar WHOIS Server:
Registrar URL: www.markmonitor.com
Updated Date: 2018-10-03T06:59:17Z
Creation Date: 2004-05-17T09:24:41Z
Registry Expiry Date: 2028-05-16T23:59:59Z
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID: CAE6765767CF74CC881450589F880C5C1-NSR
Registrant Name: Domain Administrator
Registrant Organization: Astellas Pharma Inc.
Registrant Street: 5-1, Nihonbashi-Honcho 2-chome
Registrant Street:
Registrant Street:
Registrant City: Chuo-ku
Registrant State/Province: Tokyo
Registrant Postal Code: 103-8411
Registrant Country: JP
Registrant Phone: +81.332443371
Registrant Phone Ext:
Registrant Fax: +81.352550880
Registrant Fax Ext:
Registrant Email: domain.jp@markmonitor.com
Registrant Application Purpose: P1
Registrant Nexus Category: C31/JP
Registry Admin ID: CAE6765767CF74CC881450589F880C5C1-NSR
Admin Name: Domain Administrator
Admin Organization: Astellas Pharma Inc.
Admin Street: 5-1, Nihonbashi-Honcho 2-chome
Admin Street:
Admin Street:
Admin City: Chuo-ku
Admin State/Province: Tokyo
Admin Postal Code: 103-8411
Admin Country: JP
Admin Phone: +81.332443371
Admin Phone Ext:
Admin Fax: +81.352550880
Admin Fax Ext:
Admin Email: domain.jp@markmonitor.com
Admin Application Purpose: P1
Admin Nexus Category: C31/JP
Registry Tech ID: CAE6765767CF74CC881450589F880C5C1-NSR
Tech Name: Domain Administrator
Tech Organization: Astellas Pharma Inc.
Tech Street: 5-1, Nihonbashi-Honcho 2-chome
Tech Street:
Tech Street:
Tech City: Chuo-ku
Tech State/Province: Tokyo
Tech Postal Code: 103-8411
Tech Country: JP
Tech Phone: +81.332443371
Tech Phone Ext:
Tech Fax: +81.352550880
Tech Fax Ext:
Tech Email: domain.jp@markmonitor.com
Tech Application Purpose: P1
Tech Nexus Category: C31/JP
Name Server: ns.uk.prserv.net
Name Server: dmtu.mt.ns.els-gms.att.net
Name Server: ns.de.prserv.net
Name Server: cmtu.mt.ns.els-gms.att.net
Name Server: dbru.br.ns.els-gms.att.net
Name Server: cbru.br.ns.els-gms.att.net
Name Server: ns.nl.prserv.net
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2018-11-11T16:11:09Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NeuStar, Inc., the Registry Administrator for .US, has collected this information for the WHOIS database through a .US-Accredited Registrar. This information is provided to you for informational purposes only and is designed to assist persons in determining contents of a domain name registration record in the NeuStar registry database. NeuStar makes this information available to you "as is" and does not guarantee its accuracy. By submitting a WHOIS query, you agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data: (1) to allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via direct mail, electronic mail, or by telephone; (2) in contravention of any applicable data and privacy protection laws; or (3) to enable high volume, automated, electronic processes that apply to the registry (or its systems). Compilation, repackaging, dissemination, or other use of the WHOIS database in its entirety, or of a substantial portion thereof, is not allowed without NeuStar's prior written permission. NeuStar reserves the right to modify or change these conditions at any time without prior or subsequent notification of any kind. By executing this query, in any manner whatsoever, you agree to abide by these terms. NOTE: FAILURE TO LOCATE A RECORD IN THE WHOIS DATABASE IS NOT INDICATIVE OF THE AVAILABILITY OF A DOMAIN NAME. All domain names are subject to certain additional domain name registration rules. For details, please visit our site at www.whois.us.
Канада - Лонгёй - 207.96.218.16
Videotron Ltee
Videotron Ltee
HTTP/1.1 200 OK
Date: Sat, 21 Dec 2019 14:55:17 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Set-Cookie: __cfduid=dcd385108fecfd18deaff9631a904ce181576940116; expires=Mon, 20-Jan-20 14:55:16 GMT; path=/; domain=.astellas.com; HttpOnly; SameSite=Lax; Secure
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Cache-Control: max-age=3600, public
Vary: Cookie,Accept-Encoding
X-Content-Type-Options: nosniff
Content-language: en
Last-Modified: Fri, 20 Dec 2019 20:30:00 GMT
Link: ; rel="canonical", ; rel="shortlink"
Strict-Transport-Security: max-age=1000
X-AH-Environment: 01live
X-Content-Type-Options: nosniff
X-Drupal-Cache: MISS
X-Drupal-Dynamic-Cache: UNCACHEABLE
X-Frame-Options: SameOrigin
X-Generator: Drupal 8 (https://www.drupal.org)
X-Request-ID: v-7ea5f2cc-2367-11ea-bf56-1b3486d44450
X-UA-Compatible: IE=edge
X-Request-ID: v-7ea5f2cc-2367-11ea-bf56-1b3486d44450
Age: 1353
Via: varnish
X-Cache: HIT
X-Cache-Hits: 174
CF-Cache-Status: DYNAMIC
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Server: cloudflare
CF-RAY: 548ab22eafc5cf64-IAD
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"